Jami A. Kinnucan, M.D.

Jami Kinnucan, M.D., is a Senior Associate Consultant in the Section of Gastroenterology and Hepatology at the Mayo Clinic in Jacksonville, Florida. She current serves as the Co-Director for Digital Health and Practice Integration for the Department of Medicine and the Director of Clinical Practice for the Division of Gastroenterology. Prior to relocating to the Mayo Clinic in 2022, she was an Assistant Professor of Medicine at the University of Michigan and severed as Director of Inflammatory Bowel Disease Education as well as Association Program Director for Gastroenterology and Hepatology fellowship training.

Dr. Kinnucan has expertise in the evaluation and management of patients with inflammatory bowel disease (IBD) including ulcerative colitis and Crohn's disease, as well as in the management of complex cases of microscopic colitis. In addition, she has expertise in the evaluation and management of patients who have undergone ileoanal pouch anastomosis (IPAA or J-pouch) and who are currently pregnant with IBD.

Dr. Kinnucan is frequently an invited speaker a regional and national conferences talking on the diagnosis and management of IBD. She has research interests in the use of cannabis in IBD, anxiety and depression in IBD as well as looking outcomes in at risk patient populations, including Chaldean Americans living with IBD.

Dr. Kinnucan is dedicated to both patient and provider education and the advancement of women in the field of Gastroenterology. She started the Women in GI Committee at the University of Michigan, currently serves as Co-Chair for Women in IBD Task Force for the Crohn's and Colitis Foundation National Scientific Advisory Committee and a member of the American College of Gastroenterology Women in Gastroenterology Committee. She recently started organization Florida Women in GI to connect female gastroenterology providers across the state. She also serves as a medical editor for SELF Magazine. To stay up to date on some of the latest education in IBD, follow her on Twitter at @ibdgijami.